L-DOX Injection 50 mg/25 ml contains Doxorubicin Hydrochloride in a liposomal formulation, a specialized and advanced version of a widely used anthracycline chemotherapy agent. This formulation is designed to enhance targeted drug delivery to cancer cells while minimizing damage to healthy tissues. The liposomal encapsulation improves the safety profile of doxorubicin, particularly by reducing the risk of cardiotoxicity, making it a preferred option in many oncology treatment protocols.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Doxorubicin Hydrochloride Liposome equivalent to 50 mg per 25 ml

Mechanism of Action

Doxorubicin exerts its anticancer effects by intercalating into DNA and inhibiting topoisomerase II, an enzyme essential for DNA replication and repair. This leads to the disruption of cancer cell division and induces apoptosis (programmed cell death). The liposomal carrier allows prolonged circulation in the bloodstream and preferential accumulation in tumor tissues through enhanced permeability, thereby increasing efficacy and reducing systemic toxicity.

Indications

L-DOX Injection is indicated for the treatment of:

• Breast cancer
• Ovarian cancer
• Multiple myeloma
• AIDS-related Kaposi’s sarcoma
• Other malignancies as directed by an oncologist

Dosage and Administration

• Administered intravenously under strict medical supervision.
• Dosage is determined based on body surface area, cancer type, and patient condition.
• Infusion schedules and cycles are individualized by the treating oncologist.
• Pre-medication may be used to prevent infusion-related reactions.

Benefits

• Advanced liposomal delivery enhances tumor targeting
• Reduced cardiotoxicity compared to conventional doxorubicin
• Prolonged circulation improves treatment effectiveness
• Better tolerability and safety profile
• Effective in managing various types of cancers

Side Effects

Common side effects may include:

• Nausea and vomiting
• Fatigue and weakness
• Hair loss (alopecia)
• Hand-foot syndrome
• Decreased blood cell counts (neutropenia, anemia)

Serious side effects:

• Cardiac complications (less frequent but possible)
• Severe infusion reactions
• Liver dysfunction
• Risk of secondary malignancies (rare)

Patients should seek immediate medical attention if severe adverse reactions occur.

Precautions and Warnings

• Cardiac monitoring is recommended before and during treatment.
• Use cautiously in patients with liver impairment.
• Regular monitoring of blood counts is essential.
• Avoid use during pregnancy and breastfeeding.
• Avoid live vaccines while undergoing treatment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

L-DOX Injection may interact with:

• Other chemotherapy drugs
• Cardiotoxic agents
• Immunosuppressants

Always inform the healthcare provider about all medications and therapies being used.

Storage

• Store in a refrigerator at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children.